CClinicalTrials.gg
RecruitingNCT07685418NSNPUpdated Jul 6, 2026

Ischemic Compression and Home Exercise in Non-Specific Neck Pain

An interventional study of Ischemic Compression and Home Exercise Program in Myofascial Trigger Points, Musculoskeletal Pain and Non-specific Neck Pain, sponsored by Istanbul Rumeli University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 17 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-07-06.

Sponsored by Istanbul Rumeli University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started May 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
17 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to investigate the effects of ischemic compression combined with home exercise on pain, cervical range of motion, neck disability level, and quality of life in individuals with non-specific neck pain. Participants will be divided into two groups: a treatment group receiving ischemic compression plus home exercises, and a control group receiving only home exercises. The study aims to provide clinical evidence regarding the effectiveness of combined treatment approaches for non-specific neck pain.

Read the detailed description

A total of 52 individuals, aged 18-65, with non-specific neck pain for at least 3 months, will be included in the study. Participants will be randomly assigned to either the treatment group (n=26) or the control group (n=26). Both groups will be prescribed a home exercise program. The treatment group will additionally receive ischemic compression sessions twice a week for 4 weeks.

Ischemic compression will be applied by the therapist using the thumb or a suitable contact surface, exerting controlled and gradually increasing pressure directly on the trigger point. The pressure will be maintained at the participant's pain tolerance limit (uncomfortable but bearable) and will last approximately 90 seconds for each trigger point. Participant feedback will be continuously monitored; pressure will be reduced or terminated in case of excessive pain or discomfort.

Evaluations will include the Numeric Pain Rating Scale (NPRS) for pain, the Neck Disability Index (NDI) for neck disability level, the SF-12 for quality of life, and goniometric measurements for cervical range of motion. Data will be analyzed using SPSS software.

02

Conditions studied

  • Myofascial Trigger Points
  • Musculoskeletal Pain
  • Non-specific Neck Pain
  • Neck Pain
03

In context

Musculoskeletal Pain

493 studies on the registry are indexed under Musculoskeletal Pain; 113 are open to participants now.

This study's planned enrollment of 52 is below the median of 69 across 346 interventional studies indexed under Musculoskeletal Pain.

Browse Musculoskeletal Pain studies →

Lead sponsor

Istanbul Rumeli University is the lead sponsor of 26 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Individuals aged between 18 and 65 years.
  • Diagnosis of non-specific neck pain for at least 3 months.
  • Diagnosis of non-specific neck pain for at least 3 months.
  • Voluntarily agreeing to participate and signing the informed consent form.

Exclusion criteria

Exclusion Criteria:

  • Presence of specific causes of neck pain (cervical disc herniation, radiculopathy, spinal stenosis, tumor, infection, rheumatic diseases, etc.).
  • Having undergone surgical intervention in the neck region within the last 6 months.
  • History of neurological disease.
  • History of surgery in the cervical or thoracic vertebrae.
  • Presence of impaired skin integrity in the application area.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    Experimental Group

    Ischemic compression will be applied to painful points in the neck region. Pressure will be applied until the patient's pain threshold is reached and maintained for a specific duration.

    Other: Ischemic Compression

  • Active comparator
    Control Group

    Participants will perform a structured home exercise program consisting of stretching and strengthening exercises for the cervical region.

    Other: Home Exercise Program

Interventions

  • OtherIschemic Compression

    The intervention group will receive ischemic compression applied to palpable trigger points in the upper trapezius, middle trapezius, levator scapulae, suboccipital muscles (rectus capitis posterior major/minor, obliquus capitis), and splenius capitis muscles for 90 seconds with gradually increasing pressure at the individual's pain tolerance threshold. Ischemic compression will be performed by the therapist applying perpendicular, controlled, and gradually increasing pressure to the trigger point using the thumb or an appropriate contact surface. The pressure will be maintained at the participant's tolerable pain threshold (uncomfortable but bearable) and sustained for approximately 90 seconds per trigger point. Participant feedback will be obtained during the application; in cases of excessive pain or discomfort, the pressure will be reduced or the application will be terminated. The aim of the application is to reduce local tenderness at the trigger point, regulate muscle tone, and

  • OtherHome Exercise Program

    Participants will perform a structured program consisting of stretching and strengthening exercises for the cervical region. The program will be performed twice daily for the duration of the study.

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Measured by the Numeric Pain Rating Scale (NPRS). The scale ranges from 0 (no pain) to 10 (worst possible pain). Higher scores indicate greater pain intensity.

    Time frame: Baseline and post-treatment (week 4)

Secondary outcomes

  1. Pressure Pain Threshold (PPT) as measured by Baseline Analog Pressure Algometer

    Pressure pain threshold will be assessed using a Baseline Brand Analog Pressure Algometer. Measurements will be taken bilaterally from the suboccipital, upper trapezius, and middle trapezius muscle groups. Pressure will be applied perpendicular to the muscle fibers at specific anatomical points (2 cm lateral to the spinous process of the Axis for suboccipital; between C3-C5 for upper trapezius; and between T2-T4 for middle trapezius). The values will be recorded in kg/cm². Higher values indicate a higher pain threshold.

    Time frame: Baseline and Post-treatment (Week 4)

  2. Neck Disability

    The Turkish version of the NDI will be used. It is a 10-item questionnaire covering pain, activities of daily living, and sleep. Scores range from 0 to 50, where higher scores represent higher levels of disability.

    Time frame: Baseline and Post-treatment (Week 4)

  3. Quality of Life as measured by SF-12 Health Survey

    The Turkish version of the SF-12 will be used. It is a 12-item self-report scale assessing physical and mental health. It consists of two main sub-dimensions: Physical Component Summary (PCS) and Mental Component Summary (MCS). Higher scores indicate better quality of life.

    Time frame: Baseline and Post-treatment (Week 4)

  4. Cervical Range of Motion as measured by Universal Goniometer

    Cervical range of motion (flexion, extension, lateral flexion, and rotation) will be measured in degrees using a universal goniometer according to standard clinical measurement protocols.

    Time frame: Baseline and Post-treatment (Week 4)

07

Study locations

1 of 1 sites recruiting
  • SZ Clinic Physical Therapy, Dietetics and Health Services Center
    Istanbul, Bakırköy 34140, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect participant privacy and because the data is collected as part of a Master's thesis project. The results will be made available through the final thesis publication and any subsequent peer-reviewed journal articles.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07685418
Lead sponsor
Istanbul Rumeli University
Responsible party
Muhammet Fatih Yurt (Physiotherapist, Istanbul Rumeli University) — Principal investigator
First posted
Jul 6, 2026
Start date
May 13, 2026
Primary completion
Jun 30, 2026 (estimated)
Completion
Jul 15, 2026 (estimated)
Last update
Jul 6, 2026

Study contacts

Muhammet Fatih Yurt, PT
Contact
fatihyurt66@gmail.com
+90 532 273 14 65

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion